Key Points
- Ralliant SVP Karen Bick sold 5,485 shares on March 3 at an average price of $45.00 for $246,825, reducing her stake by 10.5% to 46,756 shares valued at about $2.10 million.
- Q4 results beat—Ralliant reported $0.69 EPS vs. $0.67 expected and $554.6M revenue (up 1.2% y/y), and set guidance of Q1 2026 EPS 0.460–0.520 and FY 2026 EPS 2.220–2.420.
- The company announced a quarterly dividend of $0.05 per share (annualized $0.20), with an ex-dividend date of March 9 and a yield of about 0.4%.
Ralliant Corporation (NYSE:RAL - Get Free Report) SVP Karen Bick sold 5,485 shares of the stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $45.00, for a total value of $246,825.00. Following the transaction, the senior vice president directly owned 46,756 shares in the company, valued at $2,104,020. The trade was a 10.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Ralliant Stock Performance
Shares of RAL traded down $1.78 during trading hours on Friday, reaching $44.58. 412,194 shares of the company traded hands, compared to its average volume of 2,013,466. The stock has a market capitalization of $4.98 billion and a P/E ratio of 22.74. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. The business has a fifty day moving average price of $49.08 and a 200-day moving average price of $46.63. Ralliant Corporation has a 12-month low of $37.27 and a 12-month high of $57.02.
Ralliant (NYSE:RAL - Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating analysts' consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. Ralliant's revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.
Ralliant Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, March 9th. Ralliant's dividend payout ratio is presently 10.20%.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in RAL. Dodge & Cox acquired a new position in Ralliant in the 2nd quarter worth $523,571,000. Viking Global Investors LP acquired a new stake in Ralliant during the 2nd quarter valued at approximately $257,200,000. State Street Corp purchased a new position in shares of Ralliant during the 2nd quarter valued at approximately $213,096,000. Flossbach Von Storch SE bought a new stake in Ralliant in the second quarter valued at about $198,077,000. Finally, Millennium Management LLC raised its position in shares of Ralliant by 172.4% during the 4th quarter. Millennium Management LLC now owns 4,973,001 shares of the company's stock valued at $253,175,000 after acquiring an additional 3,147,660 shares in the last quarter.
Analysts Set New Price Targets
Several brokerages have issued reports on RAL. Zacks Research lowered Ralliant from a "hold" rating to a "strong sell" rating in a report on Monday, February 9th. Barclays dropped their price target on Ralliant from $60.00 to $52.00 and set an "overweight" rating on the stock in a research note on Monday, February 9th. Truist Financial lowered their price objective on shares of Ralliant from $62.00 to $49.00 and set a "buy" rating on the stock in a research report on Friday, February 6th. Weiss Ratings cut Ralliant from a "hold (c)" rating to a "sell (d)" rating in a research report on Thursday, February 5th. Finally, Vertical Research raised Ralliant from a "hold" rating to a "buy" rating and set a $45.00 price objective for the company in a research report on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $50.50.
Read Our Latest Report on Ralliant
About Ralliant
(
Get Free Report)
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
